FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

900000000000526001: REPLACED BY association reference set (foundation metadata concept)


Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2002. Module: SNOMED CT model component module (core metadata concept)

Descriptions:

Id Description Lang Type Status Case? Module
900000000001156010 REPLACED BY association reference set (foundation metadata concept) en Fully specified name Active Entire term case sensitive (core metadata concept) SNOMED CT model component module (core metadata concept)
900000000001157018 REPLACED BY association reference set en Synonym (core metadata concept) Active Entire term case sensitive (core metadata concept) SNOMED CT model component module (core metadata concept)


13129 members. Search Members:

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
REPLACED BY association reference set (foundation metadata concept) est un(e) (attribut) Historical association reference set (foundation metadata concept) true Inferred relationship Some

Members targetComponentId
Product containing gadoterate meglumine (medicinal product) Gadoteric acid-containing product
Product containing ethylenediamine dihydrochloride (medicinal product) Product containing ethylenediamine (product)
produit à base de soya Soyabean
Transurethral punch prostatectomy Transurethral prostatectomy
Protein and protein derivatives - dietary Protein and/or protein derivative
prématurité du fœtus Prematurity of infant (disorder)
Botulism antitoxin vaccine (product) Product containing only botulinum antitoxin (medicinal product)
Collagenase agent (substance) Collagenase
Throat preparation (product) Product manufactured as oromucosal dose form (product)
Immune thrombocytopenic purpura (disorder) Immune thrombocytopenia
r phenotype cde haplotype (finding)
r'' phenotype cdE haplotype (finding)
Interventional radiology Imaging guidance procedure (procedure)
ry phenotype CdE haplotype (finding)
Adverse reaction to component of vaccine product containing Severe acute respiratory syndrome coronavirus 2 antigen or Severe acute respiratory syndrome coronavirus 2 messenger ribonucleic acid (disorder) effet indésirable d'un composant d'un vaccin contre le coronavirus 2 du syndrome respiratoire aigu sévère (trouble)
Hereditary vascular retinopathy (disorder) Retinal vasculopathy with cerebral leukoencephalopathy and systemic manifestations
Division of palmar aponeurosis for repair of Dupuytren contracture (procedure) Division of palmar aponeurosis for correction of Dupuytren contracture (procedure)
solution pour inhalation par vapeur Solution for vapour inhalation
Somatropin(rbe) 0.6iu(0.2mg) powder and solvent for injection solution prefilled syringe (product) Somatropin only product in parenteral dose form
Somatropin(rbe) 1.2iu(0.4mg) powder and solvent for injection solution prefilled syringe (product) Somatropin only product in parenteral dose form
Somatropin(rbe) 1.8iu(0.6mg) powder and solvent for injection solution prefilled syringe (product) Somatropin only product in parenteral dose form
Somatropin(rbe) 12iu(4mg) powder and solvent for injection solution vial (product) Somatropin only product in parenteral dose form
Somatropin(rbe) 16iu(5.33mg) powder and solvent for injection solution vial (product) Somatropin only product in parenteral dose form
Somatropin(rbe) 16iu(5.33mg) injection (pdr for recon)+diluent+kit (product) Somatropin only product in parenteral dose form
Somatropin(rbe) 18iu(6mg) powder and solvent for injection solution cartridge (product) Somatropin only product in parenteral dose form
Somatropin(rbe) 2.4iu(0.8mg) powder and solvent for injection solution prefilled syringe (product) Somatropin only product in parenteral dose form
Somatropin(rbe) 3iu(1mg) powder and solvent for injection solution prefilled syringe (product) Somatropin 4 mg/mL solution for injection
Somatropin(rbe) 3.6iu(1.2mg) powder and solvent for injection solution prefilled syringe (product) Somatropin only product in parenteral dose form
Somatropin(rbe) 36iu(12mg) powder and solvent for injection solution cartridge (product) Somatropin only product in parenteral dose form
Somatropin(rbe) 4iu(1.33mg) powder and solvent for injection solution vial (product) Somatropin only product in parenteral dose form
Somatropin(rbe) 4.2iu(1.4mg) powder and solvent for injection solution prefilled syringe (product) Somatropin only product in parenteral dose form
Somatropin(rbe) 4.8iu(1.6mg) powder and solvent for injection solution prefilled syringe (product) Somatropin only product in parenteral dose form
Somatropin(rbe) 5.4iu(1.8mg) powder and solvent for injection solution prefilled syringe (product) Somatropin only product in parenteral dose form
Somatropin(rbe) 6iu(2mg) powder and solvent for injection solution prefilled syringe (product) Somatropin only product in parenteral dose form
Somatropin(rbe) 72iu(24mg) powder and solvent for injection solution cartridge (product) Somatropin only product in parenteral dose form
Somatropin(epr) 10mg/mL injection solution 1.5mL cartridge (product) Somatropin only product in parenteral dose form
Somatropin(epr) 3.33mg/mL injection solution 1.5mL cartridge (product) Somatropin only product in parenteral dose form
Somatropin(epr) 6.66mg/mL injection solution 1.5mL cartridge (product) Somatropin only product in parenteral dose form
Somatropin(rmc) 10iu(3.33mg) powder and solvent for injection solution vial (product) Somatropin only product in parenteral dose form
Somatropin(rmc) 24iu(8mg) powder and solvent for injection solution vial (product) Somatropin only product in parenteral dose form
Somatropin(rmc) 4iu(1.33mg) powder and solvent for injection solution vial (product) Somatropin only product in parenteral dose form
Support for use of traditional therapy (regime/therapy) Support for use of complementary therapy
stade I d'infection au VIH selon la classification de l'Organisation mondiale de la Santé World Health Organization 2007 Human immunodeficiency virus infection clinical stage 1
HIV WHO class II World Health Organization 2007 Human immunodeficiency virus infection clinical stage 2
HIV WHO class III World Health Organization 2007 Human immunodeficiency virus infection clinical stage 3 (finding)
stade IV d'infection au VIH selon la classification de l'Organisation mondiale de la Santé (SIDA) World Health Organization 2007 Human immunodeficiency virus infection clinical stage 4 (finding)
stade clinique I A IA
Clinical stage I B (finding) IB
Clinical stage I C (finding) IC
Clinical stage I E (finding) IE
Clinical stage I S (finding) American Joint Committee on Cancer stage IS (qualifier value)
stade clinique II A American Joint Committee on Cancer stage IIA (qualifier value)
Clinical stage II B (finding) American Joint Committee on Cancer stage IIB (qualifier value)
Clinical stage II C (finding) IIC
Clinical stage II E IIE
stade clinique III A American Joint Committee on Cancer stage IIIA (qualifier value)
stade clinique III B American Joint Committee on Cancer stage IIIB (qualifier value)
Clinical stage III C (finding) American Joint Committee on Cancer stage IIIC (qualifier value)
Clinical stage IV A American Joint Committee on Cancer stage IVA (qualifier value)
Clinical stage IV B (finding) IVB
Clinical stage IV C (finding) American Joint Committee on Cancer stage IVC (qualifier value)
stadification TNM des lymphomes non hodgkiniens American Joint Committee on Cancer allowable value
stadification TNM des tumeurs cutanées American Joint Committee on Cancer allowable value
stadification TNM des tumeurs de l'appareil digestif American Joint Committee on Cancer allowable value
stadification TNM des tumeurs de l'encéphale American Joint Committee on Cancer allowable value
stadification TNM des tumeurs de la tête et du cou American Joint Committee on Cancer allowable value
stadification TNM des tumeurs du sein American Joint Committee on Cancer allowable value
stadification TNM des tumeurs gynécologiques American Joint Committee on Cancer allowable value
stadification TNM des tumeurs ophtalmologiques American Joint Committee on Cancer allowable value
stadification TNM des tumeurs osseuses et des tissus mous American Joint Committee on Cancer allowable value
stadification TNM des tumeurs pulmonaires et pleurales American Joint Committee on Cancer allowable value
stadification TNM des tumeurs pédiatriques American Joint Committee on Cancer allowable value
stadification TNM des tumeurs urologiques American Joint Committee on Cancer allowable value
stadification TNM du lymphome de Hodgkin American Joint Committee on Cancer allowable value
Sodium stibogluconate 100mg/mL injection solution 100mL vial (product) Product containing precisely sodium stibogluconate 100 milligram/1 milliliter conventional release solution for injection (clinical drug)
Stimulant agent - non-pharmaceutical (substance) Stimulant (substance)
Streptokinase 1.5million iu powder for infusion solution vial (product) Product containing precisely streptokinase 1.5 million unit/1 vial powder for conventional release solution for injection (clinical drug)
Streptokinase 250,000iu powder for infusion solution vial (product) Product containing precisely streptokinase 250000 unit/1 vial powder for conventional release solution for injection (clinical drug)
Streptokinase 750,000iu powder for infusion solution vial (product) Product containing precisely streptokinase 750000 unit/1 vial powder for conventional release solution for injection (clinical drug)
Follow-up refused Follow-up encounter declined (situation)
Sulfadiazine 1g/4mL injection (product) Sulfadiazine 250 mg/mL solution for injection
Sumatriptan 12mg/mL injection solution 0.5mL prefilled syringe (product) Sumatriptan succinate 12 mg/mL solution for injection
Superfamily Syngamoidea (organism) Family Syngamidae (organism)
Supervisor of typists etc. Secretarial supervisor
Glaucoma suspect (situation) Glaucoma suspect
Ehlers-Danlos syndrome vascular-like type (disorder) Ehlers-Danlos syndrome classic type (disorder)
Ehlers-Danlos syndrome with periventricular heterotopia (disorder) Periventricular nodular heterotopia
syndrome d'hypertrichose-faciès acromégaloïde syndrome crânio-facio-cardio-squelettique
X-linked intellectual disability with corpus callosum agenesis and spastic quadriparesis syndrome (disorder) MASA syndrome
Cerebral gigantism jaw cysts syndrome (disorder) Gorlin syndrome
Proximal tubulopathy, diabetes mellitus, cerebellar ataxia syndrome (disorder) syndrome de Kearns-Sayre (trouble)
Familial lambdoid synostosis Simple craniosynostosis (disorder)
système de classification TNM des tumeurs malignes American Joint Committee on Cancer allowable value
HIV seropositivity séropositif
Norepinephrine acid tartrate 2mg/mL infusion concentrate 20mL ampule (product) Norepinephrine (as norepinephrine bitartrate) 1 mg/mL solution for injection
Norepinephrine acid tartrate 2mg/mL infusion concentrate 2mL ampule (product) Norepinephrine (as norepinephrine bitartrate) 1 mg/mL solution for injection
Iatrogenic tattoo (disorder) Iatrogenic tattoo
Terlipressin 1mg powder and solvent for injection solution vial (product) Terlipressin only product
Benton visual behavior test Benton visual retention test (assessment scale)
Traditional therapy (regime/therapy) Complementary therapy (regime/therapy)
Additional preoperative therapy instituted by anesthetist (procedure) Preoperative procedure

Start Previous Page 131 of 132 End


Reference Sets

Canada French language reference set (foundation metadata concept)

Reference set descriptor

Back to Start